Vemurafenib

Product number: C3450
CAS number: 918504-65-1
Molecular formula: C₂₃H₁₈ClF₂N₃O₃S
Molecular weight: 489,92 g.mol-1
Min. purity: 95,00 %
Synonyms: PLX 4032
Solubility: refer to COA

Stability: ≥ 1 year
Shipping: 24/48h for products in stock

Make a request

Product Number: C3450

Size

Qty

Description

Vemurafenib is intended for Pharmaceuticals applications. All information about Vemurafenib is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. Connect to your member account to consult the documents.

Recommendation

Sorafenib

Details

Regorafenib

Details

Dabrafenib

Details

Encorafenib

Details

Cookie name	Provider	Purpose	Expiry
cookiesplus	www.alsachim.com	Stores your cookie preferences.	1 year
PrestaShop-#	www.alsachim.com	This cookie helps keep user sessions open while they are visiting a website, and help them make orders and many more operations such as: cookie add date, selected language, used currency, last product category visited, last seen products, client identification, name, first name, encrypted password, email linked to the account, shopping cart identification.	480 hours

Cookie name	Provider	Purpose	Expiry
ads/ga-audiences	Google	These cookies are used by Google AdWords to re-engage visitors that are likely to convert to customers based on the visitor’s online behaviour across websites.	Session
NID	Google	Registers a unique ID that identifies a returning user's device. The ID is used for targeted ads.	6 months
VISITOR_INFO1_LIVE	youtube.com	Tries to estimate the users' bandwidth on pages with integrated YouTube videos.	179 days
YSC	youtube.com	Registers a unique ID to keep statistics of what videos from YouTube the user has seen.	Session
yt-remote-connected-devices	youtube.com	Stores the user's video player preferences using embedded YouTube video	Persistent
yt-remote-device-id	youtube.com	Stores the user's video player preferences using embedded YouTube video	Persistent

Vemurafenib

Description

Related products

Recommendation

Sorafenib

Regorafenib

Dabrafenib

Encorafenib